ELEVAI Labs develops aesthetic and medical-grade skin care for the physician-dispensed market, with a focus on leveraging a proprietary stem cell exosome technology.

Cosmetic industry veteran James R. Headley is joiningELEVAI LABS, INC. as a strategic advisor. 

Mr. Headley, previously CEO of ZO Skin Health, will support the ELEVAI management team as it evaluates strategic growth initiatives, product launches and partnerships. Headley will also support ELEVAI in business development and developing relationships with key opinion leaders in the aesthetic space. 

 “I am pleased to join the ELEVAI Labs Team as a Strategic Advisor,” shares Mr. Headley in a news release. “I believe that ELEVAI is the most scientifically advanced stem cell exosome technology and medical skincare available for physicians and their patients. Jordan R. Plews, Ph.D. has created the most advanced delivery of mesenchymal stem cell exosomes for post-procedure and patient home maintenance. The positive effects of ELEVAI post-procedure use will change how physicians think about post-procedure treatment and patients will readily see the benefits of daily home maintenance.”

 After beginning his career at F&R Lazarus Department (Federated Department Stores) now Macy's, he spent nine years at the Estee Lauder Companies. He left to become vice president of sales at Warner Cosmetics, which eventually became the Ralph Lauren Fragrance Division of L’Oréal.

During his time as President and CEO of ZO Skin Health, Mr. Headley launched the ZO Medical products that eventually catapulted ZO into the No. 1 position in the medical skincare dispensing space. During his time at ZO Skin Health, sales went from $2 million annually to more than $100 million in annual sales. In 2020, the majority stake of ZO Skin Health was sold to the American alternative investment management company Blackstone.

“We are thrilled to have Mr. Headley on the ELEVAI team,” shares Chris Kraneiss Chief Commercial Officer of ELEVAI Labs. “James is the perfect person to help us take ELEVAI to the next level in sales, customer service, industry recognition, and overall innovation. His expertise is invaluable to the future of ELEVAI and the growth of regenerative skincare.”